US Compounding Issues Recall For Medications over Sterility Concerns
A pharmaceutical compounding company is recalling the entirety of its sterile product collection.
US Compounding, Inc. made the announcement this week after the discovery that it cannot guarantee the sterility of products. All lots of sterile products aseptically compounded and packaged by USC and that remain within expiry are subject to the recall. The recall does not pertain to any non-sterile compounded medications.
The affected products were distributed nationwide to patients, providers, hospitals, or clinics between March 14, 2015 and September 9, 2015.
For a list of all recalled products, see the U.S. Compounding press release (PDF).
If the sterility of compounds is compromised, patients may be at risk. The company is asking all patients and providers that received the recalled compounded products to discontinue use and quarantine it until further instructions are received on how to return the product.
Customers with questions can contact U.S. Compounding at (800) 718-3588 or (501) 327-1222 extension 254.